Streetbeat News

Partnerships

MICS

Singing Machine (NASDAQ: MICS) partners with Stingray (TSX:RAY, RAY.B) to launch a new in-car karaoke system with vocal scoring and gamification, debuting at CES 2024. The system includes a karaoke app with 100,000+ songs and a microphone with pitch detection and vocal enhancements. The partnership aims to tap into the growing in-car entertainment market, offering a safe and engaging experience for passengers.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:17 pm

NVRI

Harsco Environmental, a division of Enviri Corporation (NYSE:NVRI), has renewed a multi-year services contract with Bahrain's SULB Company. This marks the third consecutive renewal since 2012, emphasizing the trust and partnership between the two companies. The 5-year contract includes slag and scrap management, product handling, yard management, briquetting services, and slag processing. The renewal, effective from Jan. 1, 2024, showcases Harsco's commitment to quality, safety, and sustainability.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:14 pm

BIGC

BigCommerce (NASDAQ:BIGC) has announced a strategic partnership with Marketplacer to launch the BigCommerce Marketplacer Connector, enabling customers to transform their online stores into multi-vendor marketplaces. This connector, developed by Web Force 5, allows for near-real-time syncing of seller data, cross-border scalability, low coding requirements, and rapid data exchange. The DOM, Australia's leading design outlet, has successfully integrated this solution to enhance its marketplace functionalities and improve customer experience. The partnership aims to help retailers increase sales, maximize revenue, and provide seamless shopping experiences.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:02 pm

ACN

Accenture (NYSE:ACN) has invested in QuantHealth, an AI-powered clinical trial design company, through Accenture Ventures. QuantHealth's platform uses AI to simulate clinical trials, aiming to reduce costs and increase efficiency in drug development. The technology is based on a dataset of 350 million patients and can predict trial outcomes, optimize trial designs, and potentially lower the risk of trial failures. While financial terms were not disclosed, the investment is part of Accenture Ventures' Project Spotlight, which supports disruptive enterprise technologies.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:01 pm

GOOG

GOOGL

LLY

NVS

Isomorphic Labs, an Alphabet Inc spin-off, has partnered with Eli Lilly and Novartis AG for AI-driven drug discovery. The deals are valued at around $3 billion, with Isomorphic receiving $45 million upfront from Eli Lilly and potentially $1.7 billion in milestones, and $37.5 million upfront from Novartis with up to $1.2 billion in incentives. Isomorphic uses DeepMind's AlphaFold 2 AI for predicting protein structures, aiding in drug design. Despite a £2.4 million loss in 2021, Isomorphic is expanding, including a new Swiss office. Google Cloud also launched AI tools for healthcare data consolidation.

Portfolio Pulse from Anusuya Lahiri

January 08, 2024 | 12:58 pm

ENVX

Enovix and Group14 have announced a collaboration to develop and enhance the performance and efficiency of lithium-ion silicon batteries, aligning with their dedication to innovation, renewable energy, and customer satisfaction.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:55 pm

SDGR

Schrödinger, a company that develops chemical simulation software for pharmaceutical and biotechnology research, has announced an expanded three-year software agreement with illy, a renowned coffee company. The agreement will allow illy to utilize Schrödinger's software to enhance its coffee products. This collaboration signifies a unique application of Schrödinger's technology outside its typical pharmaceutical domain, potentially opening new market opportunities for the company.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:34 pm

REGN

Medison Pharma has entered into an agreement with Regeneron Pharmaceuticals to commercialize Libtayo, a cancer treatment drug, in multiple countries. This partnership could potentially expand the market reach of Libtayo and enhance its sales, benefiting Regeneron's revenue stream and market presence in the oncology sector.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:32 pm

PLUR

Pluri has announced the launch of PluriCDMO, a new business division focused on providing cell therapy manufacturing services. This move positions Pluri as a Contract Development and Manufacturing Organization (CDMO) within the $5.2 billion cell and gene therapy market. The new division aims to assist companies in developing and manufacturing transformative cell therapies.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:28 pm

BABA

BIDU

NVDA

Alibaba Group Holding Limited (NYSE:BABA) stock is trading lower due to reports of reducing orders for Nvidia Corp's (NASDAQ:NVDA) chips. This shift is attributed to Chinese companies' growing interest in local options and in-house developments. Major Chinese firms like Baidu Inc (NASDAQ:BIDU) and ByteDance are also turning to domestic chip producers such as Huawei Technologies. Despite this, Alibaba.com showcased its machine learning advancements at CES in Las Vegas, indicating a commitment to global expansion. Alibaba's stock value decreased by over 34% last year, and BABA shares were down 2.44% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

January 08, 2024 | 12:26 pm